Interpace Biosciences, Inc.

OTCPK:IDXG Stock Report

Market Cap: US$11.7m

Interpace Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IDXG?
Owner TypeNumber of SharesOwnership Percentage
Institutions143,8573.27%
Individual Insiders1,038,49123.6%
General Public3,216,28673.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 26.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.5%
Peter Kamin
638,099US$1.7m0%no data
5.68%
Douglas Singer
250,000US$665.9k0%no data
2.25%
Peter H. Kamin Family Foundation, Endowment Arm
99,187US$264.2k0%25.92%
1.86%
Thomas Burnell
81,737US$217.7k0%no data
1.04%
Christopher McCarthy
45,680US$121.7k49.4%no data
1.02%
3K Limited Partnership
44,670US$119.0k0%4.27%
0.43%
Robert Gorman
18,759US$50.0k0%no data
0.056%
Stephen Sullivan
2,459US$6.5k0%no data
0.04%
Joseph Keegan
1,757US$4.7k0%no data